In summary, our current findings demonstrate that KD may ameliorate lipid deposition in type 2 diabetic mice by downregulating PES1 modulated acetylation of SREBP1c and inflammation pathways. This evidence concerns the gene PES1 and type 2 diabetes mellitus.